You can reach Allison on Signal at AllisonDeAngelis.01. A new company is making hay from an R&D shift at Denali Therapeutics, acquiring several of its neuroscience drug candidates and raising ...

SOUTH SAN FRANCISCO, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to ...

While Denali Therapeutics Inc. (NASDAQ:DNLI) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 15% in the last quarter.